Expert Perspective on ASCO20 Breast Cancer Research

Dr. Zeina Nahleh: none disclosed. Dr. Zeina Nahleh Zeina Nahleh, MD, FACP, Chair of the Department of Hematology-Oncology and Director of the Cleveland Clinic Florida Maroone Cancer Center HER2CLIMB Patients with HER2-positive breast cancer have a 50% chance of developing brain metastases, resulting in poor…

Read the full article here

Related Articles